We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.47%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.94B
AUM Growth
+$184M
Cap. Flow
-$79.5M
Cap. Flow %
-2.7%
Top 10 Hldgs %
42.7%
Holding
135
New
34
Increased
27
Reduced
33
Closed
29

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$53.9M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
BIIB icon
Biogen
BIIB
+$40.8M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$36.6M
5
ULTA icon
Ulta Beauty
ULTA
+$35M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$57.2M
2
MRK icon
Merck
MRK
+$43.5M
3
WSM icon
Williams-Sonoma
WSM
+$40.2M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$38.7M
5
LOW icon
Lowe's Companies
LOW
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.15%
2 Consumer Staples 11.86%
3 Consumer Discretionary 11.13%
4 Technology 1.98%
5 Industrials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVYA
126
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
– –
-736,000
Closed -$11.2M
BIOR
127
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
– –
-1,600
Closed -$3.61M
CFMS
128
DELISTED
Conformis, Inc. Common Stock
CFMS
– –
-299,095
Closed -$6.26M
ETTX
129
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
– –
-3,510,981
Closed -$7.16M
ATRS
130
DELISTED
Antares Pharma, Inc.
ATRS
– –
-428,000
Closed -$1.16M
HRC
131
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-164,000
Closed -$13.7M
ALXN
132
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-500,000
Closed -$57.2M
GNMK
133
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-792,000
Closed -$11.2M
AMAG
134
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-4,120,000
Closed -$38.7M
MNK
135
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-40,000
Closed -$3.89M
2 3 4 5
6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Armistice Capital held 135 positions worth $2.94B, up 6.7% from $2.76B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Armistice Capital's Q4 2020 filing shows 34 new, 27 increased, 33 reduced and 29 closed positions. Its largest new stake was Walmart Inc: 1,110,675 shares worth $53.4M. The largest sale was Alexion Pharmaceuticals, an estimated $57.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2020 buy was Walmart Inc: 1,110,675 shares worth $53.4M.
  • Armistice Capital added most to Biogen in Q4 2020, an estimated $40.8M increase.
  • Armistice Capital's biggest Q4 2020 reduction was Energizer, cutting an estimated $29.6M.
  • Armistice Capital fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $57.2M.
  • Armistice Capital's ten largest holdings make up 43% of its $2.94B portfolio in Q4 2020.
  • Armistice Capital opened 34 new positions and closed 29 in Q4 2020.
  • Armistice Capital's portfolio value rose 6.7% quarter-over-quarter to $2.94B.

Based on Armistice Capital's 13F filing for Q4 2020, filed 16 Feb 2021.